|
Genetic Studies of Insulin and Diabetes Clinical Trials Data presented on Clinical Trials Search is not meant to be a substitute for qualified medical advice, visits or professional assistance with a genuine dr.. We are not doctors. Always consult your mD about Genetic Studies of Insulin and Diabetes conditions. Clinical Trials Search.org is a site devoted to listing clinical research studies in human subjects. Genetic Studies of Insulin and Diabetes Clinical research trials and Genetic Studies of Insulin and Diabetes medical trials take place in many of places throughout the U.S.A.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials usually evaluate the effectiveness of new does drugs. The purpose of the studies / projects is to solve specific human healthcare questions. Clinical trials are a popular way for mDs, government agencies, and private sector companies to find cures for all varieties of conditions, like Genetic Studies of Insulin and Diabetes. Genetic Studies of Insulin and Diabetes Clinical Trials and other clinical trials allow for volunteers to have health treatment options before they are available to the masses. Many times the human subjects acquire professional assistance for free of charge, and sometimes they are compensated for their time. Occasionally there is a cost for a Genetic Studies of Insulin and Diabetes clinical trial. Test subjects typically obtain the finest healthcare available for their Genetic Studies of Insulin and Diabetes condition. Dangers are a reality, nevertheless, and might include additional or frequent doctor trips, medical dangers (possibly life-jeopardising), and/or the treatment being ineffectual. Trials are federally regulated with strict guidelines to protect clinical trials patients.
|
|
|
|
|
|
|
Home > "G" Clinical Trials Conditions > Genetic Studies of Insulin and Diabetes Genetic Studies of Insulin and Diabetes
Genetic Studies of Insulin and Diabetes
For Condition: Diabetes Mellitus,Insulin Resistance
Status: Recruiting
Sponsor(s): National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) ,
Synopsis: The study will allow researchers to obtain blood, plasma, DNA, and RNA for genetic studies of insulin. There will be a focus on the causes of insulin resistance and diabetes mellitus. Insulin is a hormone found in the body that controls the level of sugar in the blood. Insulin resistance refers to conditions like diabetes when insulin does not work properly. In this study researchers would like to compare patients with diabetes and other forms of insulin resistance to normal individuals. The study will investigate how insulin attaches to cells. Researchers will take 4 to 6 ounces (100-150 ml) of blood from adult patients and may request up to 12 ounces (one unit) of blood if necessary. Skin samples may be taken for a biopsy if further genetic testing is necessary. In addition some patients may be asked not to eat for up to 72 hours prior to testing.
Details: The purpose of this protocol is to enable us to obtain adequate blood or tissue samples to study the molecular mechanisms underlying various causes of insulin resistance and diabetes mellitus. Patients with any evidence for insulin resistance will be eligible to participate in this study. We particularly focus our study on the following four groups of patients: 1. Patients with various syndromes of lipoatrophy, lipodystrophy 2. Patients with mutations on the insulin receptor gene 3. Patients with autoantibodies to the insulin receptor 4. Patients with severe forms of insulin resistance In addition, patients displaying unusual phenotypic features (i.e. presence of acanthosis nigricans) in association with hyperinsulinemia (i.e. fasting insulin levels greater than 30 microgramsU/mL) or clinical diabetes mellitus may be eligible to be studied at NIH. The work-up will include all or some of the following studies: 1. Routine biochemical profile 2. Fasting insulin, glucose, HbA1c, lipid profile, lipoprotein profile, IGF-1 level, leptin level 3. A panel of hormone levels: thyroid and sex hormones, pituitary hormones, adrenal hormones and growth hormone 4. Blood samples for genetic studies 5. Oral glucose tolerance test 6. Intravenous glucose tolerance test 7. In vitro insulin or IGF-1 binding The total quantity of blood will be within the approved NIH guidelines appropriate to the individual's age and size. In addition, some subjects may undergo skin biopsy for the establishment of fibroblast cell lines. Mostly, patients with lipoatrophy and lipodystrophy may be asked to undergo a muscle and/or bone marrow biopsy to broaden the molecular studies. DEXA analysis and anthropometric measurements are performed when medically indicated during the diagnosis and evaluation to correlate markers of insulin resistance with parameters of whole body composition. In a novel component of the study, we aim to study the biochemical and molecular changes that occur with standard therapies (such as high dose insulin, continuous insulain therapy, metformin, and TZD's) used for the treatment of insulin resistance and diabetes.
Eligibility:
Study Type: Observational, Natural History
Minimum Age/Maximum Age: /
Genders: Both
Protocol Entry Criteria: INCLUSION/EXCLUSION CRITERIA At least one of the following is required: Hyperinsulinemia (i.e. greater than 30 microgramsU/mL). Clinical presence of diabetes. Phenotypic features suggesting a defect in glucose/lipid metabolism: Acanthosis nigricans; Lipoatrophy/lipodystrophy; Lipomatosis; Xanthomata; Fatty liver. Family members of patients with known disease states of insulin action.
Total Enrollment: 9999
Location and Contact Information:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) *Recruiting*
Bethesda, Maryland, 20892
United States
Recruiting Patient and Public Liaison Office 1-800-411-1222
Additional Information:
Study ID Numbers: 760006; 76-DK-0006
Study Start Date: January 30, 1976
Record last reviewed: January 7, 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00001987
Other Insulin Resistance Studies:
1. Proactive Diabetes Case Management
2. Urinary Vitamin C Loss in Diabetic Subjects
3. Patterns and natural history of insulin secretion in islet cell transplant recipients and controls
4. A clinical trial to prevent the complications of insulin resistance (including type-2 diabetes)
5. Epidemiology of Idiopathic Dilated Cardiomyopathy (Washington, DC Dilated Cardiomyopathy Study)
Related Studies:
Other Insulin Resistance Clinical Trials
Other Maryland Clinical Trials
Other Bethesda Clinical Trials
Genetic Studies of Insulin and Diabetes
|
|
|
|
|
|
|
|